Current analytical approaches for characterizing nanoparticle sizes in pharmaceutical research
Source abstract
Abstract
Nanotechnologies exploit a material’s 10−9 nanometric scale properties, which differ in physicochemical and biological properties. Various biological mechanisms of the human body activate at the nanometric scale. Nanoparticles (NPs) can traverse via natural obstacles to find new delivery targets and engage with DNA or small proteins at various levels, making NPs useful in pharmaceutical, biomaterial, and diagnostic applications. Producing nanomaterials for specific uses requires controlling synthetic NP’s size distribution, shape, surface chemistry, dispersion, aggregation stability, elemental, and nanocrystalline content. NPs are becoming increasingly relevant in fundamental research and applications. The size measurement of NPs still poses a challenge for many researchers and pharmaceutical companies. NPs may frequently be assessed using several techniques, including dynamic light scattering, nanoparticle tracking analysis, tunable resistive pulse sensing, atomic force microscopy, and disc centrifugation, but there are advantages and disadvantages associated with each technique. As per regulatory requirements, the particle size of nanoparticles used in biomedical applications requires an orthogonal approach for characterizations. Therefore, a combinatorial characterization approach is needed to measure the sizes of nanoparticles in pharmaceutical formulations. This review provides a piece of detailed knowledge on recent advancements in analytical techniques with their sample preparations, data interpretations, operational principles, and critical strategies of each technique used for measuring nanoparticle size in various pharmaceutical formulations and vaccine research which will help researchers choose the best appropriate techniques for measuring NP’s size. Graphical abstract
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery · Protein Interaction Studies and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Mahmood S, Mandal UK, Chatterjee B, Taher M (2017) Advanced characterizations of nanoparticles for drug delivery: investigating their properties through the techniques used in their evaluations. Nanotechnol Rev 6(4):355–372. https://doi.org/10.1515/ntrev-2016-0050. (Walter de Gruyter GmbH)10.1515/ntrev-2016-0050 ↗
2. Raval N, Maheshwari R, Kalyane D, Youngren-Ortiz SR, Chougule MB, Tekade RK (2018) Importance of physicochemical characterization of nanoparticles in pharmaceutical product development. In Basic Fundamentals of Drug Delivery, Elsevier, pp 369–400. https://doi.org/10.1016/B978-0-12-817909-3.00010-810.1016/B978-0-12-817909-3.00010-8 ↗
3. Coty JB, Vauthier C (2018) Characterization of nanomedicines: a reflection on a field under construction needed for clinical translation success. J Control Release 275:254–268. https://doi.org/10.1016/j.jconrel.2018.02.013. (Elsevier B.V.)10.1016/j.jconrel.2018.02.013 ↗
4. Tomalia DA, Naylor AM, Goddard WA (1990) Starburst dendrimers: molecular‐level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 29(2):138–175. https://doi.org/10.1002/anie.19900138110.1002/anie.199001381 ↗
5. Hourani R, Kakkar A (2010) Advances in the elegance of chemistry in designing dendrimers. Macromol Rapid Commun 31(11):947–974. https://doi.org/10.1002/marc.20090071210.1002/marc.200900712 ↗
6. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications - reflections on the field’. Adv Drug Deliv Rev 57(15):2106–2129. https://doi.org/10.1016/j.addr.2005.09.018. (Elsevier)10.1016/j.addr.2005.09.018 ↗
7. Svenson S (2009) Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 71(3):445–462. https://doi.org/10.1016/j.ejpb.2008.09.02310.1016/j.ejpb.2008.09.023 ↗
8. Lee CC, MacKay JA, Fréchet JMJ, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23(12):1517–1526. https://doi.org/10.1038/nbt117110.1038/nbt1171 ↗
9. Liu M, Kono K, Fréchet JMJ (2000) Water-soluble dendritic unimolecular micelles. J Control Release 65(1–2):121–131. https://doi.org/10.1016/S0168-3659(99)00245-X10.1016/S0168-3659(99)00245-X ↗
10. Wu Y, Luo Y, Wang Q (2012) Antioxidant and antimicrobial properties of essential oils encapsulated in zein nanoparticles prepared by liquid-liquid dispersion method. LWT 48(2):283–290. https://doi.org/10.1016/j.lwt.2012.03.02710.1016/j.lwt.2012.03.027 ↗
11. Li KK, Yin SW, Yang XQ, Tang CH, Wei ZH (2012) Fabrication and characterization of novel antimicrobial films derived from thymol-loaded zein-sodium caseinate (SC) nanoparticles. J Agric Food Chem 60(46):11592–11600. https://doi.org/10.1021/jf302752v10.1021/jf302752v ↗
12. Gomes C, Moreira RG, Castell-Perez E (2011) Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications. J Food Sci 76(2). https://doi.org/10.1111/j.1750-3841.2010.01985.x10.1111/j.1750-3841.2010.01985.x ↗
13. Keawchaoon L, Yoksan R (2011) Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles. Colloids Surf B Biointerfaces 84(1):163–171. https://doi.org/10.1016/j.colsurfb.2010.12.03110.1016/j.colsurfb.2010.12.031 ↗
14. Hosseini SF, Zandi M, Rezaei M, Farahmandghavi F (2013) Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study. Carbohydr Polym 95(1):50–56. https://doi.org/10.1016/j.carbpol.2013.02.03110.1016/j.carbpol.2013.02.031 ↗
15. Jeevanandam J, Chan YS, Danquah MK (2016) Nano-formulations of drugs: recent developments, impact and challenges’. Biochimie 128–129:99–112. https://doi.org/10.1016/j.biochi.2016.07.008. (Elsevier B.V.)10.1016/j.biochi.2016.07.008 ↗
16. Jeetah R, Bhaw-Luximon A, Jhurry D (2014) Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment. J Biomed Nanotechnol 10(9):1810–1840. https://doi.org/10.1166/jbn.2014.1884. (American Scientific Publishers)10.1166/jbn.2014.1884 ↗
17. Letchford K, Burt H (2007) A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 65(3):259–269. https://doi.org/10.1016/j.ejpb.2006.11.00910.1016/j.ejpb.2006.11.009 ↗
18. Vonarbourg A, Passirani C, Saulnier P, Benoit JP (2006) Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27(24):4356–4373. https://doi.org/10.1016/j.biomaterials.2006.03.03910.1016/j.biomaterials.2006.03.039 ↗
19. Jones M-C, Leroux J-C (1999) Polymeric micelles – a new generation of colloidal drug carriers. Eur J Pharm Biopharm 48(2):101–111. https://doi.org/10.1016/S0939-6411(99)00039-910.1016/S0939-6411(99)00039-9 ↗
20. Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30(11):592–599. https://doi.org/10.1016/j.tips.2009.08.00410.1016/j.tips.2009.08.004 ↗
21. Gregoriadis G, Florence AT (1993) Liposomes in drug delivery. Drugs 45(1):15–28. https://doi.org/10.2165/00003495-199345010-0000310.2165/00003495-199345010-00003 ↗
22. Sonnevilleaubrun O (2004) Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci 108–109:145–149. https://doi.org/10.1016/s0001-8686(03)00146-510.1016/s0001-8686(03)00146-5 ↗
23. Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ (2005) Nano-emulsions. Curr Opin Colloid Interface Sci 10(3–4):102–110. https://doi.org/10.1016/j.cocis.2005.06.00410.1016/j.cocis.2005.06.004 ↗
24. Mason TG, Wilking JN, Meleson K, Chang CB, Graves SM (2006) Nanoemulsions: formation, structure, and physical properties. J Phys Condensed Matter 18(41). https://doi.org/10.1088/0953-8984/18/41/R01.10.1088/0953-8984/18/41/R01 ↗
25. Jain AK, Thareja S (2019) In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery. Artif Cells Nanomed Biotechnol 47(1):524–539. https://doi.org/10.1080/21691401.2018.156145710.1080/21691401.2018.1561457 ↗
26. Akbari B, Pirhadi Tavandashti M, Zandrahimi M (2011) Particle size characterization of nanoparticles – a practical approach. IJMSE 8(2):48–56. http://ijmse.iust.ac.ir/article-1-341-en.html
27. Takechi-Haraya Y, Ohgita T, Demizu Y, Saito H, Ichi Izutsu K, Sakai-Kato K (2022) Current status and challenges of analytical methods for evaluation of size and surface modification of nanoparticle-based drug formulations. AAPS PharmSciTech 23(5). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1208/s12249-022-02303-y10.1208/s12249-022-02303-y ↗
28. Giessibl FJ (2003) Advances in atomic force microscopy. Rev Mod Phys 75:949–97810.1103/RevModPhys.75.949 ↗
29. Lamprou DA, Smith JR (2016) Applications of AFM in pharmaceutical sciences, pp 649–674. https://doi.org/10.1007/978-1-4939-4029-5_2010.1007/978-1-4939-4029-5_20 ↗
30. Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS (2022) Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics 14(4). MDPI. https://doi.org/10.3390/pharmaceutics14040883.10.3390/pharmaceutics14040883 ↗
31. Couteau O, Roebben G (2011) Measurement of the size of spherical nanoparticles by means of atomic force microscopy, In Measurement Science and Technology, Institute of Physics Publishing.https://doi.org/10.1088/0957-0233/22/6/06510110.1088/0957-0233/22/6/065101 ↗
32. Grobelny J, DelRio FW, Pradeep N, Kim DI, Hackley VA, Cook RF (2011) Size measurement of nanoparticles using atomic force microscopy’. Methods Mol Biol 697:71–82. https://doi.org/10.1007/978-1-60327-198-1_710.1007/978-1-60327-198-1_7 ↗
33. Sudarsan V (2017) Materials for hostile chemical environments’, in Materials under extreme conditions: recent trends and future prospects, Elsevier Inc., pp 129–158. https://doi.org/10.1016/B978-0-12-801300-7.00004-810.1016/B978-0-12-801300-7.00004-8 ↗
34. Goldsbury C, Green J (2005) Time-lapse atomic force microscopy in the characterization of amyloid-like fibril assembly and oligomeric intermediates. In: Amyloid proteins. Humana Press, New Jersey, pp 103–128. https://doi.org/10.1385/1-59259-874-9:10310.1385/1-59259-874-9:103 ↗
35. Mastrangelo IA et al (2006) High-resolution atomic force microscopy of soluble Aβ42 oligomers. J Mol Biol 358(1):106–119. https://doi.org/10.1016/j.jmb.2006.01.04210.1016/j.jmb.2006.01.042 ↗
36. Barinov N, Ivanov N, Kopylov A, Klinov D, Zavyalova E (2018) Direct visualization of the oligomeric state of hemagglutinins of influenza virus by high-resolution atomic force microscopy. Biochimie 146:148–155. https://doi.org/10.1016/j.biochi.2017.12.01410.1016/j.biochi.2017.12.014 ↗
37. Banerjee S, Sun Z, Hayden EY, Teplow DB, Lyubchenko YL (2017) Nanoscale dynamics of amyloid β-42 oligomers as revealed by high-speed atomic force microscopy. ACS Nano 11(12):12202–12209. https://doi.org/10.1021/acsnano.7b0543410.1021/acsnano.7b05434 ↗
38. Konno et al (n.d.) Dynamics of oligomer and amyloid fibril formation by yeast prion Sup35 observed by high-speed atomic force microscopy. https://doi.org/10.1073/pnas.1916452117/-/DCSupplemental.10.1073/pnas.1916452117/-/DCSupplemental ↗
39. Kato HE et al (2015) Structural basis for Na + transport mechanism by a light-driven Na + pump. Nature 521(7550):48–53. https://doi.org/10.1038/nature1432210.1038/nature14322 ↗
40. Dong B, Sánchez-Magraner L, Luecke H (2016) Structure of an inward proton-transporting Anabaena sensory rhodopsin mutant: mechanistic insights. Biophys J 111(5):963–972. https://doi.org/10.1016/j.bpj.2016.04.05510.1016/j.bpj.2016.04.055 ↗
41. Ward ME et al (2015) In situ structural studies of anabaena sensory rhodopsin in the E. coli membrane. Biophys J 108(7):1683–1696. https://doi.org/10.1016/j.bpj.2015.02.01810.1016/j.bpj.2015.02.018 ↗
42. Gushchin I et al (2015) Crystal structure of a light-driven sodium pump. Nat Struct Mol Biol 22(5):390–396. https://doi.org/10.1038/nsmb.300210.1038/nsmb.3002 ↗
43. Ran T et al (2013) Cross-protomer interaction with the photoactive site in oligomeric proteorhodopsin complexes. Acta Crystallogr D Biol Crystallogr 69(10):1965–1980. https://doi.org/10.1107/S090744491301757510.1107/S0907444913017575 ↗
44. Milikisiyants S et al (2017) Oligomeric structure of Anabaena sensory rhodopsin in a lipid bilayer environment by combining solid-state NMR and long-range DEER constraints. J Mol Biol 429(12):1903–1920. https://doi.org/10.1016/j.jmb.2017.05.00510.1016/j.jmb.2017.05.005 ↗
45. Jung K, Trivedi VD, Spudich JL (2003) Demonstration of a sensory rhodopsin in eubacteria. Mol Microbiol 47(6):1513–1522. https://doi.org/10.1046/j.1365-2958.2003.03395.x10.1046/j.1365-2958.2003.03395.x ↗
46. Beck M et al (2004) Nuclear pore complex structure and dynamics revealed by cryoelectron tomography. Science (1979) 306(5700):1387–1390. https://doi.org/10.1126/science.110480810.1126/science.1104808 ↗
47. Brown LS, Ernst OP (2017) Recent advances in biophysical studies of rhodopsins – oligomerization, folding, and structure. Biochim Biophys Acta – Proteins Proteom 1865(11):1512–1521. https://doi.org/10.1016/j.bbapap.2017.08.007. (Elsevier B.V.)10.1016/j.bbapap.2017.08.007 ↗
48. Wang S, Munro RA, Kim SY, Jung KH, Brown LS, Ladizhansky V (2012) Paramagnetic relaxation enhancement reveals oligomerization interface of a membrane protein. J Am Chem Soc 134(41):16995–16998. https://doi.org/10.1021/ja308310z10.1021/ja308310z ↗
49. Inoue K et al (2013) A light-driven sodium ion pump in marine bacteria. Nat Commun 4. https://doi.org/10.1038/ncomms268910.1038/ncomms2689 ↗
50. Shibata M et al (2018) Oligomeric states of microbial rhodopsins determined by high-speed atomic force microscopy and circular dichroic spectroscopy. Sci Rep 8(1). https://doi.org/10.1038/s41598-018-26606-y10.1038/s41598-018-26606-y ↗
51. Zhou L, Kurouski D (2020) Structural characterization of individual α-synuclein oligomers formed at different stages of protein aggregation by atomic force microscopy-infrared spectroscopy. Anal Chem 92(10):6806–6810. https://doi.org/10.1021/acs.analchem.0c0059310.1021/acs.analchem.0c00593 ↗
52. Oropesa-Nuñez R et al (n.d) Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy. [Online]. Available: http://www.impactjournals.com/oncotarget
53. Zhao J et al (2019) Nitration of hIAPP promotes its toxic oligomer formation and exacerbates its toxicity towards INS-1 cells. Nitric Oxide 87:23–30. https://doi.org/10.1016/j.niox.2019.02.01010.1016/j.niox.2019.02.010 ↗
54. Peltonen L (2018) Practical guidelines for the characterization and quality control of pure drug nanoparticles and nano-cocrystals in the pharmaceutical industry. Adv Drug Deliv Rev 131:101–115. https://doi.org/10.1016/j.addr.2018.06.009. (Elsevier B.V.)10.1016/j.addr.2018.06.009 ↗
55. Williams DB, Carter CB (1996) The transmission electron microscope. In Transmission electron microscopy; Springer: Boston, MA,USA, pp. 3–17. https://doi.org/10.1007/978-1-4757-2519-3_110.1007/978-1-4757-2519-3_1 ↗
56. L. Pascucci and G. Scattini (2021) Imaging extracelluar vesicles by transmission electron microscopy: coping with technical hurdles and morphological interpretation. Biochim Biophys Acta Gen Subj 1865(4). https://doi.org/10.1016/j.bbagen.2020.129648.10.1016/j.bbagen.2020.129648 ↗
57. Le Ferrand H, Duchamp M, Gabryelczyk B, Cai H, Miserez A (2019) Time-resolved observations of liquid-liquid phase separation at the nanoscale using in situ liquid transmission electron microscopy. J Am Chem Soc 141(17):7202–7210. https://doi.org/10.1021/jacs.9b0308310.1021/jacs.9b03083 ↗
58. Nakamuro T, Kamei K, Sun K, Bode JW, Harano K, Nakamura E (2022) Time-resolved atomistic imaging and statistical analysis of daptomycin oligomers with and without calcium ions. J Am Chem Soc 144(30):13612–13622. https://doi.org/10.1021/jacs.2c0394910.1021/jacs.2c03949 ↗
59. Szigetvari PD et al (2019) The quaternary structure of human tyrosine hydroxylase: effects of dystonia-associated missense variants on oligomeric state and enzyme activity. J Neurochem 148(2):291–306. https://doi.org/10.1111/jnc.1462410.1111/jnc.14624 ↗
60. Das R, Balmik AA, Chinnathambi (2020) Phagocytosis of full-length Tau oligomers by actin-remodeling of activated microglia. J Neuroinflammation 17(1). https://doi.org/10.1186/s12974-019-1694-y10.1186/s12974-019-1694-y ↗
61. Hoffmann W et al (2018) NFGAIL amyloid oligomers: the onset of beta-sheet formation and the mechanism for fibril formation. J Am Chem Soc 140(1):244–249. https://doi.org/10.1021/jacs.7b0951010.1021/jacs.7b09510 ↗
62. Sun Y et al (2019) Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide. Biochim Biophys Acta Mol Basis Dis 1865(2):434–444. https://doi.org/10.1016/j.bbadis.2018.11.02110.1016/j.bbadis.2018.11.021 ↗
63. Chen S et al (2021) Oligomeric procyanidins inhibit insulin fibrillation by forming unstructured and off-pathway aggregates. RSC Adv 11(59):37290–37298. https://doi.org/10.1039/d1ra05397c10.1039/d1ra05397c ↗
64. Singla P, Kanwar R, Sharma R, Mehta SK, Salunke DB (2021) Proficiency of nanostructured lipid carriers for the formulation of amphiphilic bile acid oligomers. Colloids Surf A Physicochem Eng Asp 611. https://doi.org/10.1016/j.colsurfa.2020.12584110.1016/j.colsurfa.2020.125841 ↗
65. Zhou X, Thompson GE (2017) Electron and photon based spatially resolved techniques. In Reference module in materials science and materials engineering, Elsevier. https://doi.org/10.1016/b978-0-12-803581-8.10140-710.1016/b978-0-12-803581-8.10140-7 ↗
66. Sousa AA, Leapman RD (2012) Development and application of STEM for the biological sciences. Ultramicroscopy 123:38–49. https://doi.org/10.1016/j.ultramic.2012.04.00510.1016/j.ultramic.2012.04.005 ↗
67. Wall JS, Simon MN, Lin BY, Vinogradov SN (2008) Mass mapping of large globin complexes by scanning transmission electron microscopy. In Methods in enzymology 436, Academic Press Inc., pp 487–501. https://doi.org/10.1016/S0076-6879(08)36027-310.1016/S0076-6879(08)36027-3 ↗
68. Carvalho PM, Felício MR, Santos NC, Gonçalves S, Domingues MM (2018) Application of light scattering techniques to nanoparticle characterization and development. Front Chem 6. Frontiers Media S.A. https://doi.org/10.3389/fchem.2018.0023710.3389/fchem.2018.00237 ↗
69. Brar SK, Verma M (2011) Measurement of nanoparticles by light-scattering techniques. TrAC – Trends Anal Chem 30(1):4–17. https://doi.org/10.1016/j.trac.2010.08.00810.1016/j.trac.2010.08.008 ↗
70. Instruments M (2007) Zetasizer nano user manual MAN0485 issue 1.1 April 2013 English
71. intro_to_dls. https://www.malvernpanalytical.com/en/learn/knowledge-center/technical-notes/tn101104dynamiclightscatteringintroduction. Accessed 26 Jan 2023
72. Ramos AP (2017) 4 - Dynamic light scattering applied to nanoparticle characterization. https://doi.org/10.1016/B978-0-323-49778-7/00004-710.1016/B978-0-323-49778-7/00004-7 ↗
73. Jose N, Deshmukh GP, Ravindra MR, Review M (2019) Dynamic light scattering: advantages and applications
74. Agrahari V, Burnouf PA, Burnouf T, Agrahari V (2019) Nanoformulation properties, characterization, and behavior in complex biological matrices: challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential. Adv Drug Deliv Rev 148:146–180. https://doi.org/10.1016/j.addr.2019.02.008. (Elsevier B.V.)10.1016/j.addr.2019.02.008 ↗
75. Morrison ED et al (2021) Dense nanolipid fluid dispersions comprising ibuprofen: single step extrusion process and drug properties. Int J Pharm 598. https://doi.org/10.1016/j.ijpharm.2021.12028910.1016/j.ijpharm.2021.120289 ↗
76. Hackley VA (2015) Measuring the size of nanoparticles in aqueous media using batch-mode dynamic light scattering. Gaithersburg, MD. https://doi.org/10.6028/NIST.SP.1200-6.10.6028/NIST.SP.1200-6 ↗
77. Badasyan A, Mavrič A, Kralj Cigić I, Bencik T, Valant M (2018) Polymer nanoparticle sizes from dynamic light scattering and size exclusion chromatography: the case study of polysilanes. Soft Matter 14(23):4735–4740. https://doi.org/10.1039/c8sm00780b10.1039/c8sm00780b ↗
78. Chen S, Tam YYC, Lin PJC, Sung MMH, Tam YK, Cullis PR (2016) Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. J Control Release 235:236–244. https://doi.org/10.1016/j.jconrel.2016.05.05910.1016/j.jconrel.2016.05.059 ↗
79. Nakamura T, Kawai M, Sato Y, Maeki M, Tokeshi M, Harashima H (2020) The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution. Mol Pharm 17(3):944–953. https://doi.org/10.1021/acs.molpharmaceut.9b0118210.1021/acs.molpharmaceut.9b01182 ↗
80. Malm AV, Corbett JCW (2019) Improved dynamic light scattering using an adaptive and statistically driven time resolved treatment of correlation data. Sci Rep 9(1):1–11. https://doi.org/10.1038/s41598-019-50077-410.1038/s41598-019-50077-4 ↗
81. Zheng T, Bott S, Huo Q (2016) Techniques for accurate sizing of gold nanoparticles using dynamic light scattering with particular application to chemical and biological sensing based on aggregate formation. ACS Appl Mater Interfaces 8(33):21585–21594. https://doi.org/10.1021/acsami.6b0690310.1021/acsami.6b06903 ↗
82. Kamiti M, Boldridge D, Ndoping LM, Remsen EE (2012) Simultaneous absolute determination of particle size and effective density of submicron colloids by disc centrifuge photosedimentometry. Anal Chem 84(24):10526–10530. https://doi.org/10.1021/AC3022086/SUPPL_FILE/AC3022086_SI_001.PDF10.1021/AC3022086/SUPPL_FILE/AC3022086_SI_001.PDF ↗
83. Kaiser JP, Zuin S, Wick P (2013) Is nanotechnology revolutionizing the paint and lacquer industry? A critical opinion. Sci Total Environ 442:282–289. https://doi.org/10.1016/j.scitotenv.2012.10.00910.1016/j.scitotenv.2012.10.009 ↗
84. Gao J, Ndong RS, Shiflett MB, Wagner NJ (2015) Creating nanoparticle stability in ionic liquid [C4mim][BF4] by inducing solvation layering. ACS Nano 9(3):3243–3253. https://doi.org/10.1021/acsnano.5b0035410.1021/acsnano.5b00354 ↗
85. Davidson AM, Brust M, Cooper DL, Volk M (2017) Sensitive analysis of protein adsorption to colloidal gold by differential centrifugal sedimentation. Anal Chem 89(12):6807–6814. https://doi.org/10.1021/acs.analchem.7b0122910.1021/acs.analchem.7b01229 ↗
86. Langevin D et al (2018) Inter-laboratory comparison of nanoparticle size measurements using dynamic light scattering and differential centrifugal sedimentation. NanoImpact 10:97–107. https://doi.org/10.1016/j.impact.2017.12.00410.1016/j.impact.2017.12.004 ↗
87. Vegad H (n.d.) An introduction to particle size characterisation by DCS do you know the real size of your nanoparticles?
88. Plüisch CS, Stuckert R, Wittemann A (2021) Direct measurement of sedimentation coefficient distributions in multimodal nanoparticle mixtures. Nanomaterials 11(4):1027. https://doi.org/10.3390/NANO11041027/S110.3390/NANO11041027/S1 ↗
89. Perez-Potti A et al (2021) In depth characterisation of the biomolecular coronas of polymer coated inorganic nanoparticles with differential centrifugal sedimentation. Sci Rep 11(1):1–12. https://doi.org/10.1038/s41598-021-84029-810.1038/s41598-021-84029-8 ↗
90. Fe, Batio, and Tio, CPS_protocol_v1 page 2/5-Several ceramics with sizes < 1 µm (ZrO
91. Wan S et al (2015) The “sweet” side of the protein corona: effects of glycosylation on nanoparticle-cell interactions. ACS Nano 9(2):2157–2166. https://doi.org/10.1021/nn506060q10.1021/nn506060q ↗
92. Monopoli MP et al (2011) Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133(8):2525–2534. https://doi.org/10.1021/ja107583h10.1021/ja107583h ↗
93. Monopoli MP, Pitek AS, Lynch I, Dawson KA (2013) Formation and characterization of the nanoparticle-protein corona. Methods Mol Biol 1025:137–155. https://doi.org/10.1007/978-1-62703-462-3_1110.1007/978-1-62703-462-3_11 ↗
94. Hühn D et al (2013) Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 7(4):3253–3263. https://doi.org/10.1021/nn305929510.1021/nn3059295 ↗
95. Röcker C, Pötzl M, Zhang F, Parak WJ, Nienhaus GU (2009) A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 4(9):577–580. https://doi.org/10.1038/nnano.2009.19510.1038/nnano.2009.195 ↗
96. Malloy A, Carr B (2006) Nanoparticle tracking analysis - the halo™ system. Part Part Syst Charact 23(2):197–204. https://doi.org/10.1002/ppsc.20060103110.1002/ppsc.200601031 ↗
97. Kim A, Ng WB, Bernt W, Cho NJ (2019) Validation of size estimation of nanoparticle tracking analysis on polydisperse macromolecule assembly. Sci Rep 9(1). https://doi.org/10.1038/s41598-019-38915-x10.1038/s41598-019-38915-x ↗
98. Introduction to nanoparticle tracking analysis (NTA) measurement principle of ZetaView®. [Online]. Available: http://www.particle-metrix.de. Accessed 23 Jan 2023
99. Gruia F, Parupudi A, Polozova A (2015) Practical considerations for detection and characterization of sub-micron particles in protein solutions by nanoparticle tracking analysis. PDA J Pharm Sci Technol 69(3):427–439. https://doi.org/10.5731/pdajpst.2015.0105110.5731/pdajpst.2015.01051 ↗
100. Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27(5):796–810. https://doi.org/10.1007/s11095-010-0073-210.1007/s11095-010-0073-2 ↗